These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22927250)

  • 1. Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.
    Simmons S; Knoll M; Drewell C; Wolf I; Mollenkopf HJ; Bouquet C; Melchers F
    Blood; 2012 Nov; 120(18):3688-98. PubMed ID: 22927250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor dose links development to disease.
    Sigvardsson M
    Blood; 2012 Nov; 120(18):3630-1. PubMed ID: 23118213
    [No Abstract]   [Full Text] [Related]  

  • 3. Ectopic expression of PAX5 promotes maintenance of biphenotypic myeloid progenitors coexpressing myeloid and B-cell lineage-associated genes.
    Anderson K; Rusterholz C; Månsson R; Jensen CT; Bacos K; Zandi S; Sasaki Y; Nerlov C; Sigvardsson M; Jacobsen SE
    Blood; 2007 May; 109(9):3697-705. PubMed ID: 17218387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient retroviral transduction of human B-lymphoid and myeloid progenitors: marked inhibition of their growth by the Pax5 transgene.
    Sekine R; Kitamura T; Tsuji T; Tojo A
    Int J Hematol; 2008 May; 87(4):351-362. PubMed ID: 18415655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
    Imoto N; Hayakawa F; Kurahashi S; Morishita T; Kojima Y; Yasuda T; Sugimoto K; Tsuzuki S; Naoe T; Kiyoi H
    J Biol Chem; 2016 Feb; 291(9):4723-31. PubMed ID: 26703467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors.
    Hsu CL; King-Fleischman AG; Lai AY; Matsumoto Y; Weissman IL; Kondo M
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):672-7. PubMed ID: 16407117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
    Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
    Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program.
    Itoh-Nakadai A; Hikota R; Muto A; Kometani K; Watanabe-Matsui M; Sato Y; Kobayashi M; Nakamura A; Miura Y; Yano Y; Tashiro S; Sun J; Ikawa T; Ochiai K; Kurosaki T; Igarashi K
    Nat Immunol; 2014 Dec; 15(12):1171-80. PubMed ID: 25344725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losing B cell identity.
    Carotta S; Nutt SL
    Bioessays; 2008 Mar; 30(3):203-7. PubMed ID: 18293359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
    Nasr MR; Rosenthal N; Syrbu S
    Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.
    Liu GJ; Cimmino L; Jude JG; Hu Y; Witkowski MT; McKenzie MD; Kartal-Kaess M; Best SA; Tuohey L; Liao Y; Shi W; Mullighan CG; Farrar MA; Nutt SL; Smyth GK; Zuber J; Dickins RA
    Genes Dev; 2014 Jun; 28(12):1337-50. PubMed ID: 24939936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.
    Heavey B; Charalambous C; Cobaleda C; Busslinger M
    EMBO J; 2003 Aug; 22(15):3887-97. PubMed ID: 12881423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX5 promotes pre-B cell proliferation by regulating the expression of pre-B cell receptor and its downstream signaling.
    Xue K; Song J; Yang Y; Li Z; Wu C; Jin J; Li W
    Mol Immunol; 2016 May; 73():1-9. PubMed ID: 27016671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
    Souabni A; Jochum W; Busslinger M
    Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative splicing of the trout Pax5 gene and identification of novel B cell populations using Pax5 signatures.
    MacMurray E; Barr M; Bruce A; Epp L; Zwollo P
    Dev Comp Immunol; 2013 Oct; 41(2):270-81. PubMed ID: 23796789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-221 redirects precursor B cells to the BM and regulates their residence.
    Knoll M; Simmons S; Bouquet C; Grün JR; Melchers F
    Eur J Immunol; 2013 Sep; 43(9):2497-506. PubMed ID: 23716169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
    Somasundaram R; Jensen CT; Tingvall-Gustafsson J; Åhsberg J; Okuyama K; Prasad M; Hagman JR; Wang X; Soneji S; Strid T; Ungerbäck J; Sigvardsson M
    Blood; 2021 Jun; 137(22):3037-3049. PubMed ID: 33619557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development.
    Cotta CV; Zhang Z; Kim HG; Klug CA
    Blood; 2003 Jun; 101(11):4342-6. PubMed ID: 12560221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of essential B cell development genes in horses with common variable immunodeficiency.
    Tallmadge RL; Such KA; Miller KC; Matychak MB; Felippe MJ
    Mol Immunol; 2012 Jun; 51(2):169-76. PubMed ID: 22464097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.